Navigation Links
Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
Date:12/23/2010

am confident that our diverse product portfolio, rich pipeline and global presence position us well for long-term growth and success."

About J. Kevin BuchiJ. Kevin Buchi was appointed Chief Operating Officer of Cephalon in 2010. In this role, he managed the company's global sales and marketing functions, as well as product manufacturing, business development and investor relations.  From 1996 to 2009, Mr. Buchi served as Chief Financial Officer and, from 2004, head of business development for the company. At various times in his career at Cephalon, Mr. Buchi has had oversight of corporate finance, accounting, information systems, facilities, human resources and administration. Mr. Buchi joined Cephalon in 1991 as controller.

Mr. Buchi graduated from Cornell University with a Bachelor of Arts degree in chemistry. He was a synthetic organic chemist for the Eastman Kodak Company before going on to obtain a master's degree in management from the J.L. Kellogg Graduate School of Management at Northwestern University. He worked for a large public accounting firm before beginning his career in the pharmaceutical industry with E.I. du Pont de Nemours and Company in 1983. He is a certified public accountant.

About Cephalon, Inc.Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon to Webcast Investor Day
2. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
3. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
4. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
5. Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
6. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
7. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
8. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
9. Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
10. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
11. Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  Orexigen Therapeutics, Inc. (Nasdaq: ... Cannell has joined as Chief Commercial Officer. ... Contrave® /Mysimba™ (naltrexone HCl / bupropion HCl extended ... global commercial strategy, assuming responsibilities previously held by ... commercial effort through the U.S. launch of Contrave, ...
(Date:3/30/2015)... 2015 NiQ Health, "the ... the high level interface capabilities of their CarePlus™ ... The partnership between CarePlus™ and ClinicAll ... allows patients to choose the most appropriate alarm ... The advanced functionality of CarePlus™ allows patient alarms ...
(Date:3/30/2015)... , March 30, 2015  Edison Nation Medical, ... worldwide search for product innovations to assist seniors ... ideas uncovered during the 8-week search will be ... commercialization.  Invention ideas can be submitted through a ... through May 28, 2015. The objective ...
Breaking Medicine Technology:Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3
... BELL, Pa., Aug. 8, 2011 Inovio Pharmaceuticals, Inc. (NYSE AMEX: ... ended June 30, 2011. Total revenue was $2.4 million ... 2011, compared to $1.1 million and $2.5 million for the same ... and six months ended June 30, 2011, were $7.6 million and ...
... Aug. 5, 2011 Jury selection in the second trial ... begun in Clark County, Nevada. The Nevada Supreme Court lifted ... it was determined by the court that nurse David Hambrick, ... "does not possess the requisite skill, knowledge or experience to ...
Cached Medicine Technology:Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 2Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 3Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 4Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 5Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 6Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 7Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 8Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 9Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 10Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 11Second Trial in the Largest Hepatitis C Outbreak in U.S. Begins - Mainor Eglet Law Firm Files for Plaintiffs 2
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an ... six new treatment options for dealing with stubborn, unwanted fat. ... topical product. The other three technologies use devices to deliver ... freezing cold ( CoolSculpting ) to kill fat cells. (see: ... us to permanently remove unwanted fat," says Dr. Simon Ourian, ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 A key ... neurological diseases plays an important role in the response ... scientists from the Icahn School of Medicine at Mount ... diseases have long been associated with inflammation, part of ... when immune cells home in to attack invaders like ...
(Date:3/30/2015)... Vancouver, BC (PRWEB) March 30, 2015 ... recently announced that the majority of cases taken up ... trial. This means that the lawyers help protect the ... through the tedious court process. The announcement comes across ... their primary job is to provide convenience to their ...
(Date:3/30/2015)... Jose, California (PRWEB) March 30, 2015 ... population and government efforts to develop and establish chronic ... management therapies. Growth in the market is poised to ... as a result of the increase in chronic health ... diseases, and rheumatoid arthritis, among others. While conventional treatment ...
(Date:3/30/2015)... March 30, 2015 On March 19th, ... Field, home of the Detroit Lions, LiveToBeSober.org hosted the ... recognized pastors, ministers and bishops as well as other ... the audience at the luncheon, including retired Detroit Lions ... Per Wickstrom and two survivors of their own personal ...
Breaking Medicine News(10 mins):Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2
... researchers has constructed a model that predicts how an ... airliners. ,The study, "Modeling the Worldwide Spread ... in the January issue of the journal PLoS Medicine. ... world's largest-scale epidemic simulation of its kind. ...
... suggests that TEMPE, a topical anesthetic spray has the ... with premature ejaculation and might be useful// as a ... in the February issue of the urology journal BJU ... studied 54 men with premature ejaculation, randomly assigning them ...
... Rs.350 million to provide health insurance to around 1.2 ... H.D. Kumaraswamy announced// here Wednesday. ,"We are aware ... thousands of families. We have decided to provide health ... has been fixed for the project this year," Kumaraswamy ...
... that a novel needle-free vaccine approach// is effective and ... of Alzheimer’s disease. ,The transdermal, or ... of preventing or treating the devastating neurodegenerative disease with ... ,The study was published online this week in The ...
... effective procedure to combat obesity in adolescents,// according to a ... first study to evaluate the lap band in patients under ... average lost about 50% of their excess weight by one ... issue of the Journal of Pediatric Surgery. Currently, the lap ...
... Women with a history of abuse by intimate partners ... women with no history of such abuse, according to ... plan. ,The higher costs and utilization continued ... Group Health, the University of Washington (UW), and the ...
Cached Medicine News:Health News:Scientists Assess Risk of Flu Pandemic Spread Via Global Airlines 2Health News:Scientists Assess Risk of Flu Pandemic Spread Via Global Airlines 3Health News:TEMPE Spray Delays Ejaculation 2Health News:Karnataka's Free Health Insurance to the Poor 2Health News:Transdermal Vaccine Effective in Treating Alzheimer's Disease in Mice 2Health News:Stomach Banding Surgery Effective for Adolescents 2Health News:Stomach Banding Surgery Effective for Adolescents 3Health News:Health Care Costs - Significant for Abused Women 2
Subretinal Fluid Cannula, Straight; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip....
Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 5mm, 30g (0.30)....
...
Lacrimal Cannula, Curved - Open End, 21gSize: 21g x 1-1/2"....
Medicine Products: